Hiroshi Yanagawa

Jichi Medical University — Japan

Medicine · Health Sciences

63h-index17.5kcitations504works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Kawasaki Disease and Coronary Complications(114), Coronary Artery Anomalies(69), RNA and protein synthesis mechanisms(50), Cardiovascular Issues in Pregnancy(35), Monoclonal and Polyclonal Antibodies Research(32)

Publications502 total

Netrin-1 inhibits the attachment and internalization of Hepatitis B virus for hepatocyte infection
PLoS Pathogens·2025Open Access
Geometric Brownian motion with random observation time as generalization of the double Pareto distribution
Journal of Mathematical Physics·2025Open Access
The ladder and readout cables of intermediate silicon strip detector for sPHENIX
Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment·2025· 1 citedOpen Access
Wnt/Beta-Catenin Signaling Regulates Hepatitis B Virus cccDNA Levels
Preprints.org·2025Open Access
The Ladder and Readout Cables of Intermediate Silicon Strip Detector for sPHENIX
arXiv (Cornell University)·2025Open Access
Epidemiology of Kawasaki disease in Japan in 2021–2022: Results of the 27th nationwide survey
Pediatrics International·2025· 9 cited
Study on Transmitting Antennas for Long-Range Microwave Wireless Power Transfer Projects
2025Open Access
Introduction of the Study Results of the Moon Electrical Power Systems
2024
Functional involvement of endothelial lipase in hepatitis B virus infection
Hepatology Communications·2023· 9 citedOpen Access
Supplementary Figure 1 from Modulation of Glucose Metabolism by CD44 Contributes to Antioxidant Status and Drug Resistance in Cancer Cells
2023Open Access
Supplementary Figure 2 from Modulation of Glucose Metabolism by CD44 Contributes to Antioxidant Status and Drug Resistance in Cancer Cells
2023Open Access
Supplementary Figure 3 from Modulation of Glucose Metabolism by CD44 Contributes to Antioxidant Status and Drug Resistance in Cancer Cells
2023Open Access
Supplementary Figure 5 from Modulation of Glucose Metabolism by CD44 Contributes to Antioxidant Status and Drug Resistance in Cancer Cells
2023Open Access
Supplementary Figure 1 from Modulation of Glucose Metabolism by CD44 Contributes to Antioxidant Status and Drug Resistance in Cancer Cells
2023Open Access
Supplementary Methods, Figure Legends 1-7 from Modulation of Glucose Metabolism by CD44 Contributes to Antioxidant Status and Drug Resistance in Cancer Cells
2023Open Access
Supplementary Figure 3 from Modulation of Glucose Metabolism by CD44 Contributes to Antioxidant Status and Drug Resistance in Cancer Cells
2023Open Access
Supplementary Figure 7 from Modulation of Glucose Metabolism by CD44 Contributes to Antioxidant Status and Drug Resistance in Cancer Cells
2023Open Access
Supplementary Figure 6 from Modulation of Glucose Metabolism by CD44 Contributes to Antioxidant Status and Drug Resistance in Cancer Cells
2023Open Access
Supplementary Figure 4 from Modulation of Glucose Metabolism by CD44 Contributes to Antioxidant Status and Drug Resistance in Cancer Cells
2023Open Access
Supplementary Figure 5 from Modulation of Glucose Metabolism by CD44 Contributes to Antioxidant Status and Drug Resistance in Cancer Cells
2023Open Access
page 1 of 26Next →

Frequent Co-authors

Yosikazu Nakamura(24), Mayumi Yashiro(17), Ritei Uehara(11), Tomisaku Kawasaki(9), Izumi Oki(7), I Shigematsu(5), Yasuko Aoyama(5), Nobuhide Doi(5), Shunichi Kosugi(4), Masako Hasebe(4), Masaru Tomita(4), Kazuhiko Kotani(4), Etsuko Miyamoto‐Sato(3), Yoshikazu Nakamura(3), Nobuko Makino(3), Ryusuke Ae(3), Yasuyuki Fujita(3), M. Yashiro(3), Hideaki Takashima(2), Jane C. Burns(2)